{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:06:08Z","timestamp":1793703968327,"version":"4.5.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-230x-14-27","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T18:03:27Z","timestamp":1392314607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C"],"prefix":"10.1186","volume":"14","author":[{"given":"Kumiko","family":"Mera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Uto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yozo","family":"Yoshimine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Nosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Tabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Oketani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"1061_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1445-5994.2004.00615.x","volume":"34","author":"NC Teoh","year":"2004","unstructured":"Teoh NC, Farrell GC: Management of chronic hepatitis C virus infection: a new era of disease control. Intern Med J. 2004, 34: 324-337. 10.1111\/j.1445-5994.2004.00615.x.","journal-title":"Intern Med J"},{"key":"1061_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0168-8278(03)00479-3","volume":"40","author":"KQ Hu","year":"2004","unstructured":"Hu KQ, Kyulo NL, Esrailian E, Thompson K, Chase R, Hillebrand DJ, Runyon BA: Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States. J Hepatol. 2004, 40: 147-154.","journal-title":"J Hepatol"},{"key":"1061_CR3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s10620-006-9418-4","volume":"52","author":"KQ Hu","year":"2007","unstructured":"Hu KQ, Currie SL, Shen H, Cheung RC, Ho SB, Bini EJ, McCracken JD, Morgan T, Br\u00e4u N, Schmidt WN, Jeffers L, Wright TL, VA HCV-001 Study Group: Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans. Dig Dis Sci. 2007, 52: 570-578. 10.1007\/s10620-006-9418-4.","journal-title":"Dig Dis Sci"},{"key":"1061_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","volume":"49","author":"DL White","year":"2008","unstructured":"White DL, Ratziu V, El-Serag HB: Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol. 2008, 49: 831-844. 10.1016\/j.jhep.2008.08.006.","journal-title":"J Hepatol"},{"key":"1061_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.22392","volume":"48","author":"IH Cua","year":"2008","unstructured":"Cua IH, Hui JM, Kench JG, George J: Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. Hepatology. 2008, 48: 723-731. 10.1002\/hep.22392.","journal-title":"Hepatology"},{"key":"1061_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","volume":"134","author":"R Moucari","year":"2008","unstructured":"Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P: Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology. 2008, 134: 416-423. 10.1053\/j.gastro.2007.11.010.","journal-title":"Gastroenterology"},{"key":"1061_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1084\/jem.189.2.413","volume":"189","author":"T Miyazaki","year":"1999","unstructured":"Miyazaki T, Hirokami Y, Matsuhashi N, Takatsuka H, Naito M: Increased susceptibility of thymocytes to apotosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J Exp Med. 1999, 189: 413-422. 10.1084\/jem.189.2.413.","journal-title":"J Exp Med"},{"key":"1061_CR8","doi-asserted-by":"publisher","first-page":"12072","DOI":"10.1073\/pnas.1101841108","volume":"108","author":"J Kurokawa","year":"2011","unstructured":"Kurokawa J, Nagano H, Ohara O, Kubota N, Kadowaki T, Arai S, Miyazaki T: Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue. Proc Natl Acad Sce USA. 2011, 108: 12072-12077. 10.1073\/pnas.1101841108.","journal-title":"Proc Natl Acad Sce USA"},{"key":"1061_CR9","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1253\/circj.CJ-11-0891","volume":"75","author":"T Miyazaki","year":"2011","unstructured":"Miyazaki T, Kurokawa J, Arai S: AIMing at metabolic syndrome.-Towards the development of novel therapies for metabolic disease via apoptosis inhibitor of macrophage (AIM). Circ J. 2011, 75: 2522-2531. 10.1253\/circj.CJ-11-0891.","journal-title":"Circ J"},{"key":"1061_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","volume":"14","author":"K Rabe","year":"2008","unstructured":"Rabe K, Lehrke M, Parhofer KG, Broedl UC: Adipokines and insulin resistance. Mol Med. 2008, 14: 741-751.","journal-title":"Mol Med"},{"key":"1061_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/jhep.2002.33684","volume":"36","author":"H Honda","year":"2002","unstructured":"Honda H, Ikejima K, Hirose M, Yoshikawa M, Lang T, Enomoto N, Kitamura T, Takei Y, Sato N: Leptin is required for fibrogenic responses induced by thioacetamid in the murine liver. Hepatology. 2002, 36: 12-21.","journal-title":"Hepatology"},{"key":"1061_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1042\/BJ20102148","volume":"440","author":"JA Handy","year":"2011","unstructured":"Handy JA, Fu PP, Kumar P, Mells JE, Sharma S, Saxene NK, Anania FA: Adiponectin inhibits leptin signaling via multiple mechanisms to exert protective effects against hepatic fibrosis. Biochem J. 2011, 440: 385-395. 10.1042\/BJ20102148.","journal-title":"Biochem J"},{"key":"1061_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.beem.2005.07.008","volume":"19","author":"A Koerner","year":"2005","unstructured":"Koerner A, Kratzsch J, Kiess W: Adipocytokines: leptin\u2014the classical, resistin\u2014the controversical, adiponectin\u2014the promising, and more to come. Best Pract Res Clin Endocrinol Metab. 2005, 19: 525-546. 10.1016\/j.beem.2005.07.008.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1061_CR14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.arcmed.2009.04.008","volume":"40","author":"A Tiftikci","year":"2009","unstructured":"Tiftikci A, Atug O, Yilmaz Y, Eren F, Ozdemir FT, Yapali S, Ozdogan O, Celikel CA, Imeryuz N, Tozun N: Serum lebels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis. Arch Med Res. 2009, 40: 294-298. 10.1016\/j.arcmed.2009.04.008.","journal-title":"Arch Med Res"},{"key":"1061_CR15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1080\/00365520802085387","volume":"43","author":"E Tsochatzis","year":"2008","unstructured":"Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ: Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scand J Gastroenterol. 2008, 43: 1128-1136. 10.1080\/00365520802085387.","journal-title":"Scand J Gastroenterol"},{"key":"1061_CR16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/hep.23046","volume":"50","author":"F Marra","year":"2009","unstructured":"Marra F, Bertolani C: Adipokines in liver diseases. Hepatology. 2009, 50: 957-969. 10.1002\/hep.23046.","journal-title":"Hepatology"},{"key":"1061_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pathophys.2008.05.001","volume":"15","author":"C Bertolani","year":"2008","unstructured":"Bertolani C, Marra F: The role of adipokines in liver fibrosis. Pathophysiology. 2008, 15: 91-101. 10.1016\/j.pathophys.2008.05.001.","journal-title":"Pathophysiology"},{"key":"1061_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/hep.21703","volume":"46","author":"IH Cua","year":"2007","unstructured":"Cua IH, Hui JM, Bandara P, Kench JG, Farrell GC, McCaughan GW, George J: Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology. 2007, 46: 66-73. 10.1002\/hep.21703.","journal-title":"Hepatology"},{"key":"1061_CR19","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999, 22: 1462-1470. 10.2337\/diacare.22.9.1462.","journal-title":"Diabetes Care"},{"key":"1061_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1386-6346(01)00180-2","volume":"23","author":"K Matsumoto","year":"2002","unstructured":"Matsumoto K, Yoshimoto J, Sugo H, Kojima K, Futagawa S, Matsumoto T: Relationship between the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C. Hepatol Res. 2002, 23: 196-201. 10.1016\/S1386-6346(01)00180-2.","journal-title":"Hepatol Res"},{"key":"1061_CR21","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","volume":"130","author":"G Leandro","year":"2006","unstructured":"Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, Adinolfi LE, Asselah T, Jonsson JR, Smedile A, Terrault N, Pazienza V, Giordani MT, Giostra E, Sonzogni A, Ruggiero G, Marcellin P, Powell EE, George J, Negro F, HCV Meta-Analysis (on) Individual Patients' Data Study Group: Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology. 2006, 130: 1636-1642. 10.1053\/j.gastro.2006.03.014.","journal-title":"Gastroenterology"},{"key":"1061_CR22","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1373\/clinchem.2007.089144","volume":"53","author":"B Gangadharan","year":"2007","unstructured":"Gangadharan B, Antrobus R, Dwek RA, Zitzmann N: Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem. 2007, 53: 1792-1799. 10.1373\/clinchem.2007.089144.","journal-title":"Clin Chem"},{"key":"1061_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1471-2407-9-271","volume":"9","author":"J Gray","year":"2009","unstructured":"Gray J, Chattopadhyay D, Beale GS, Patman GL, Miele L, King BP, Stewart S, Hudson M, Day CP, Manas DM, Reeves HL: A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. BMC Cancer. 2009, 9: 271-10.1186\/1471-2407-9-271.","journal-title":"BMC Cancer"},{"key":"1061_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.bbrc.2012.05.018","volume":"422","author":"Y Iwamura","year":"2012","unstructured":"Iwamura Y, Mori M, Nakashima K, Mikami T, Murayama K, Arai S, Miyazaki T: Apoptosis inhibitor of macrophage (AIM) diminishes lipid droplet-coating proteins leading to lipolysis in adipocytes. Biochem Biophys Res Commun. 2012, 422: 476-481. 10.1016\/j.bbrc.2012.05.018.","journal-title":"Biochem Biophys Res Commun"},{"key":"1061_CR25","doi-asserted-by":"publisher","first-page":"22910","DOI":"10.1074\/jbc.M100324200","volume":"276","author":"I Haruta","year":"2001","unstructured":"Haruta I, Kato Y, Hashimoto E, Minjares C, Kennedy S, Uto H, Yamauchi K, Kobayashi M, Yusa S, M\u00fcller U, Hayashi N, Miyazaki T: Association of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting macrophage survival and enhancing phagocytotic function of macrophages. J Biol Chem. 2001, 276: 22910-22914. 10.1074\/jbc.M100324200.","journal-title":"J Biol Chem"},{"key":"1061_CR26","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1053\/j.gastro.2007.08.003","volume":"133","author":"A Dolganiuc","year":"2007","unstructured":"Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, Mandrekar P, Szabo G: Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology. 2007, 133: 1627-1636. 10.1053\/j.gastro.2007.08.003.","journal-title":"Gastroenterology"},{"key":"1061_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-2001-12925","volume":"21","author":"EM Brunt","year":"2001","unstructured":"Brunt EM: Nonalcoholic steatohepatitis: definition and pathology. Semin liver Dis. 2001, 21: 3-16. 10.1055\/s-2001-12925.","journal-title":"Semin liver Dis"},{"key":"1061_CR28","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gut.2005.082701","volume":"55","author":"E Novo","year":"2006","unstructured":"Novo E, Marra F, Zamara E, Valfr\u00e8 Di Bonzo L, Monitillo L, Cannito S, Petrai I, Mazzocca A, Bonacchi A, De Franco RS, Colombatto S, Autelli R, Pinzani M, Parola M: Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut. 2006, 55: 1174-1182.","journal-title":"Gut"},{"key":"1061_CR29","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","volume":"125","author":"JM Hui","year":"2003","unstructured":"Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J: Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology. 2003, 125: 1695-1704. 10.1053\/j.gastro.2003.08.032.","journal-title":"Gastroenterology"},{"key":"1061_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jhep.2004.09.022","volume":"42","author":"A Muzzi","year":"2005","unstructured":"Muzzi A, Leandro G, Rubbia Brandt L, James R, Keiser O, Malinverni R, Dufour JF, Helbling B, Hadengue A, Gonvers JJ, M\u00fcllhaupt B, Cerny A, Mondelli MU, Negro F, Swiss Hepatitis C Cohort Study: Inrulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol. 2005, 42: 41-46. 10.1016\/j.jhep.2004.09.022.","journal-title":"J Hepatol"},{"key":"1061_CR31","first-page":"193","volume":"21","author":"NA Baig","year":"2001","unstructured":"Baig NA, Herrine SK, Rubin R: Liver disease and diabetes mellitus. Clin Lab Med. 2001, 21: 193-207.","journal-title":"Clin Lab Med"},{"key":"1061_CR32","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1002\/hep.510290632","volume":"29","author":"G Svegliati-Baroni","year":"1999","unstructured":"Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G, Orlandoni P, Macarri G, Perego L, Benedetti A, Folli F: Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology. 1999, 29: 1743-1751. 10.1002\/hep.510290632.","journal-title":"Hepatology"},{"key":"1061_CR33","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1053\/jhep.2001.28055","volume":"34","author":"V Paradis","year":"2001","unstructured":"Paradis V, Perlemuter G, Bonvoust F, Dargere D, Parfait B, Vidaud M, Conti M, Huet S, Ba N, Buffet C, Bedossa P: High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology. 2001, 34: 738-744. 10.1053\/jhep.2001.28055.","journal-title":"Hepatology"},{"key":"1061_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1471-2288-11-158","volume":"11","author":"A Borai","year":"2011","unstructured":"Borai A, Livingstone C, Kaddam I, Ferns G: Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol. 2011, 11: 158-10.1186\/1471-2288-11-158.","journal-title":"BMC Med Res Methodol"},{"key":"1061_CR35","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1572-0241.2003.07450.x","volume":"98","author":"M Romero-G\u00f3mez","year":"2003","unstructured":"Romero-G\u00f3mez M, Castellano-Megias VM, Grande L, Irles JA, Cruz M, Nogales MC, Alc\u00f3n JC, Robles A: Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Am J Gastroenterol. 2003, 98: 1135-1141. 10.1111\/j.1572-0241.2003.07450.x.","journal-title":"Am J Gastroenterol"},{"key":"1061_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1365-2893.2003.00483.x","volume":"11","author":"T Piche","year":"2004","unstructured":"Piche T, Vandenbos F, Abakar-Mahamat A, Vanbiervliet G, Barjoan EM, Calle G, Giudicelli J, Ferrua B, Laffont C, Benzaken S, Tran A: The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C. J Viral Hepat. 2004, 11: 91-96. 10.1046\/j.1365-2893.2003.00483.x.","journal-title":"J Viral Hepat"},{"key":"1061_CR37","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jhep.2005.05.030","volume":"43","author":"JR Jonsson","year":"2005","unstructured":"Jonsson JR, Moschen AR, Hickman IJ, Richardson MM, Kaser S, Clouston AD, Powell EE, Tilg H: Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol. 2005, 43: 929-936. 10.1016\/j.jhep.2005.05.030.","journal-title":"J Hepatol"},{"key":"1061_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jhep.2005.02.044","volume":"43","author":"CJ Liu","year":"2005","unstructured":"Liu CJ, Chen PJ, Jeng YM, Huang WL, Yang WS, Lai MY, Kao JH, Chen DS: Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J Hepatol. 2005, 43: 235-242. 10.1016\/j.jhep.2005.02.044.","journal-title":"J Hepatol"},{"key":"1061_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/hep.20519","volume":"41","author":"L Fartoux","year":"2005","unstructured":"Fartoux L, Chazouill\u00e8res O, Wendum D, Poupon R, Serfaty L: Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology. 2005, 41: 82-87. 10.1002\/hep.20519.","journal-title":"Hepatology"},{"key":"1061_CR40","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1872-034X.2011.00886.x","volume":"41","author":"Y Itoh","year":"2011","unstructured":"Itoh Y, Nishimura T, Yamaguchi K, Yokomizo C, Fujii H, Minami M, Nagao Y, Sumida Y, Hashimoto H, Umemura A, Shima T, Okanoue T, Yoshikawa T: Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy. Hepatol Res. 2011, 41: 1145-1152. 10.1111\/j.1872-034X.2011.00886.x.","journal-title":"Hepatol Res"},{"key":"1061_CR41","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s00535-012-0550-y","volume":"47","author":"M Ohnishi","year":"2012","unstructured":"Ohnishi M, Tsuge M, Kohno T, Zhang Y, Abe H, Hyogo H, Kimura Y, Miki D, Hiraga N, Imamura M, Takahashi S, Ochi H, Hayes CN, Tanaka S, Arihiro K, Chayama K: IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients. J Gastroenterol. 2012, 47: 834-844. 10.1007\/s00535-012-0550-y.","journal-title":"J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-14-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-14-27\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-14-27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-14-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:14:51Z","timestamp":1630552491000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-14-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-14-27","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]},"assertion":[{"value":"16 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}